Continuous Metabolic Monitoring: A Game Changer in Cell and Gene Therapy Research

[Article Title]

American Pharmaceutical Review recently had the opportunity to interview Dr. Tia Harmon, a distinguished expert in the field of cell and gene therapy and a Technical Product Sales Specialist for PHC Corporation of North America (PHCNA). Dr. Harmon shed light on the latest advancements in cell and gene therapy, particularly in the realm of metabolic monitoring and its impact on treatment development.

Download this Q&A to learn more about her important insights on cell metabolism research and how it directly contributes to the development of innovative disease treatments, a critical area of focus in today’s pharmaceutical industry.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.